Eunji Jo

857 total citations
29 papers, 520 citations indexed

About

Eunji Jo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Eunji Jo has authored 29 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Eunji Jo's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Tuberculosis Research and Epidemiology (3 papers). Eunji Jo is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Tuberculosis Research and Epidemiology (3 papers). Eunji Jo collaborates with scholars based in South Korea, Germany and Estonia. Eunji Jo's co-authors include Jeewon Lee, Marc P. Windisch, Eun Jung Lee, Koo Chul Kwon, Ju Hee Ryu, Jaewon Yang, Kwangmeyung Kim, Boram Lee, Young‐Wan Kwon and June Huh and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Hepatology.

In The Last Decade

Eunji Jo

28 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eunji Jo South Korea 11 198 135 93 91 79 29 520
Mingrong Cheng China 14 204 1.0× 101 0.7× 104 1.1× 47 0.5× 99 1.3× 22 572
Cintia W. Rivero Argentina 17 367 1.9× 124 0.9× 84 0.9× 94 1.0× 88 1.1× 34 588
Xiaoxi Ouyang China 17 339 1.7× 126 0.9× 81 0.9× 85 0.9× 129 1.6× 31 777
Sufang Ma China 15 278 1.4× 70 0.5× 46 0.5× 36 0.4× 89 1.1× 45 817
Yun He China 11 342 1.7× 97 0.7× 91 1.0× 54 0.6× 29 0.4× 52 637
Iain Macpherson United States 17 475 2.4× 181 1.3× 71 0.8× 58 0.6× 40 0.5× 36 763
Je-Wen Liou Taiwan 15 293 1.5× 71 0.5× 33 0.4× 34 0.4× 100 1.3× 45 756
Peng Peng China 14 227 1.1× 84 0.6× 33 0.4× 48 0.5× 45 0.6× 104 657
Jan Hodek Czechia 15 297 1.5× 121 0.9× 142 1.5× 37 0.4× 81 1.0× 45 872
Jingjing Yan China 14 217 1.1× 68 0.5× 52 0.6× 30 0.3× 59 0.7× 41 632

Countries citing papers authored by Eunji Jo

Since Specialization
Citations

This map shows the geographic impact of Eunji Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eunji Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eunji Jo more than expected).

Fields of papers citing papers by Eunji Jo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eunji Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eunji Jo. The network helps show where Eunji Jo may publish in the future.

Co-authorship network of co-authors of Eunji Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Eunji Jo. A scholar is included among the top collaborators of Eunji Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eunji Jo. Eunji Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duraisamy, G, Eunji Jo, Kyu‐Ho Park, et al.. (2022). Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion. Heliyon. 8(9). e10465–e10465. 5 indexed citations
2.
ElHefnawi, Mahmoud, Eunji Jo, Mahmoud M. Tolba, et al.. (2022). Drug repurposing through virtual screening and in vitro validation identifies tigecycline as a novel putative HCV polymerase inhibitor. Virology. 570. 9–17. 2 indexed citations
3.
Heo, Yunseok, Hyeongseop Jeong, Ji-Hye Yun, et al.. (2021). Structural and Functional Characterizations of Cancer Targeting Nanoparticles Based on Hepatitis B Virus Capsid. International Journal of Molecular Sciences. 22(17). 9140–9140. 1 indexed citations
4.
Kim, Hye-Jin, et al.. (2021). Performance of QuantaMatrix Microfluidic Agarose Channel system integrated with mycobacteria growth indicator tube liquid culture. Applied Microbiology and Biotechnology. 105(14-15). 6059–6072. 3 indexed citations
5.
Jo, Eunji, Hyun Kim, Alexander König, et al.. (2021). Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors. Antiviral Research. 196. 105195–105195. 3 indexed citations
6.
Yang, Jaewon, Alexander König, Soonju Park, et al.. (2021). A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals. JHEP Reports. 3(4). 100296–100296. 8 indexed citations
7.
Huê, Bùi Thị Bửu, Phuong Hong Nguyen, Quang De Tran, et al.. (2020). Benzimidazole Derivatives as Novel Zika Virus Inhibitors. ChemMedChem. 15(15). 1453–1463. 28 indexed citations
8.
Jo, Eunji, Dong-Kyun Ryu, Alexander König, et al.. (2020). Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor. Antiviral Research. 175. 104709–104709. 9 indexed citations
9.
Lee, Sang-Yeop, Eunji Jo, Hyun Jung Kim, et al.. (2019). Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs. Frontiers in Microbiology. 10. 706–706. 4 indexed citations
10.
König, Alexander, Jaewon Yang, Eunji Jo, et al.. (2019). Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells. Journal of Hepatology. 71(2). 289–300. 53 indexed citations
11.
Huh, June, Young Wan Kwon, Donghyun Park, et al.. (2019). Biological conversion of methane to methanol through genetic reassembly of native catalytic domains. Nature Catalysis. 2(4). 342–353. 79 indexed citations
12.
Andersen, Petter I., Aleksandr Ianevski, Eunji Jo, et al.. (2019). Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine. Viruses. 11(10). 964–964. 65 indexed citations
13.
Jung, Yong‐Gyun, Hye-Jin Kim, Sang-Yeop Lee, et al.. (2018). A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis. Scientific Reports. 8(1). 8651–8651. 10 indexed citations
14.
Jo, Eunji, Hong Yeol Yoon, Hyo‐Jung Lee, et al.. (2018). Nonimmunogenetic Viral Capsid Carrier with Cancer Targeting Activity. Advanced Science. 5(8). 1800494–1800494. 13 indexed citations
15.
Kwon, Koo Chul, Eunji Jo, Young‐Wan Kwon, et al.. (2017). Superparamagnetic Gold Nanoparticles Synthesized on Protein Particle Scaffolds for Cancer Theragnosis. Advanced Materials. 29(38). 60 indexed citations
16.
Park, Dong‐Sik, Eunji Jo, Jihyun Choi, et al.. (2017). Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor. European Journal of Medicinal Chemistry. 140. 65–73. 10 indexed citations
17.
Lee, Myungeun, Jaewon Yang, Eunji Jo, et al.. (2017). A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner. Scientific Reports. 7(1). 44676–44676. 14 indexed citations
18.
Oh, Sangmi, Jaewon Yang, Eunji Jo, et al.. (2016). Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions. Antiviral Research. 129. 39–46. 9 indexed citations
19.
Lee, Myungeun, Jaewon Yang, Eunji Jo, et al.. (2016). Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner. Antiviral Research. 132. 287–295. 19 indexed citations
20.
Lee, Eun Jung, Sang Jin Lee, Ju Hee Ryu, et al.. (2015). Engineered Proteinticles for Targeted Delivery of siRNA to Cancer Cells. Advanced Functional Materials. 25(8). 1279–1286. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingrong Cheng Breakdown of academic impact, for papers by Cintia W. Rivero Breakdown of academic impact, for papers by Xiaoxi Ouyang Breakdown of academic impact, for papers by Sufang Ma Breakdown of academic impact, for papers by Yun He Breakdown of academic impact, for papers by Iain Macpherson Breakdown of academic impact, for papers by Je-Wen Liou Breakdown of academic impact, for papers by Peng Peng Breakdown of academic impact, for papers by Jan Hodek Breakdown of academic impact, for papers by Jingjing Yan
Rankless by CCL
2026